Rapid Influenza Diagnostic Test (RIDT) Industry Research Report 2025

Summary

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

According to APO Research, The global Rapid Influenza Diagnostic Test (RIDT) market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Rapid Influenza Diagnostic Test (RIDT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Rapid Influenza Diagnostic Test (RIDT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Rapid Influenza Diagnostic Test (RIDT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Rapid Influenza Diagnostic Test (RIDT) include BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation and BioMerieux, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rapid Influenza Diagnostic Test (RIDT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Influenza Diagnostic Test (RIDT).
The Rapid Influenza Diagnostic Test (RIDT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rapid Influenza Diagnostic Test (RIDT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Rapid Influenza Diagnostic Test (RIDT) Segment by Company

BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Rapid Influenza Diagnostic Test (RIDT) Segment by Type

Digital RIDTs
Conventional RIDT
Rapid Influenza Diagnostic Test (RIDT) Segment by Application

Hospitals
POCT
Others
Rapid Influenza Diagnostic Test (RIDT) Segment by Application

Hospitals
POCT
Others
Rapid Influenza Diagnostic Test (RIDT) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Influenza Diagnostic Test (RIDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rapid Influenza Diagnostic Test (RIDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Influenza Diagnostic Test (RIDT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Rapid Influenza Diagnostic Test (RIDT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Rapid Influenza Diagnostic Test (RIDT) by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Digital RIDTs
2.2.3 Conventional RIDT
2.3 Rapid Influenza Diagnostic Test (RIDT) by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospitals
2.3.3 POCT
2.3.4 Others
2.4 Assumptions and Limitations
3 Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Type
3.1 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Type (2020-2025)
3.2 Global Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Type (2026-2031)
4 Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Application
4.1 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Application (2020-2025)
4.2 Global Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Perspective (2020-2031)
5.2 Global Rapid Influenza Diagnostic Test (RIDT) Growth Trends by Region
5.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Region (2020-2025)
5.2.3 Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Region (2026-2031)
5.3 Rapid Influenza Diagnostic Test (RIDT) Market Dynamics
5.3.1 Rapid Influenza Diagnostic Test (RIDT) Industry Trends
5.3.2 Rapid Influenza Diagnostic Test (RIDT) Market Drivers
5.3.3 Rapid Influenza Diagnostic Test (RIDT) Market Challenges
5.3.4 Rapid Influenza Diagnostic Test (RIDT) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Rapid Influenza Diagnostic Test (RIDT) Players by Revenue
6.1.1 Global Top Rapid Influenza Diagnostic Test (RIDT) Players by Revenue (2020-2025)
6.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Players (2020-2025)
6.2 Global Rapid Influenza Diagnostic Test (RIDT) Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Rapid Influenza Diagnostic Test (RIDT) Head Office and Area Served
6.4 Global Rapid Influenza Diagnostic Test (RIDT) Players, Product Type & Application
6.5 Global Rapid Influenza Diagnostic Test (RIDT) Manufacturers Established Date
6.6 Global Rapid Influenza Diagnostic Test (RIDT) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size (2020-2031)
7.2 North America Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2020-2025)
7.4 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size (2020-2031)
8.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2020-2025)
8.4 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size (2020-2031)
9.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2020-2025)
9.4 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Rapid Influenza Diagnostic Test (RIDT) Market Size (2020-2031)
10.2 South America Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2020-2025)
10.4 South America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size (2020-2031)
11.2 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2020-2025)
11.4 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 BD
12.1.1 BD Company Information
12.1.2 BD Business Overview
12.1.3 BD Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.1.4 BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.1.5 BD Recent Developments
12.2 Abbot (Alere)
12.2.1 Abbot (Alere) Company Information
12.2.2 Abbot (Alere) Business Overview
12.2.3 Abbot (Alere) Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.2.4 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.2.5 Abbot (Alere) Recent Developments
12.3 Quidel
12.3.1 Quidel Company Information
12.3.2 Quidel Business Overview
12.3.3 Quidel Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.3.4 Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.3.5 Quidel Recent Developments
12.4 Roche
12.4.1 Roche Company Information
12.4.2 Roche Business Overview
12.4.3 Roche Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.4.4 Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.4.5 Roche Recent Developments
12.5 Thermo Fisher Scientific
12.5.1 Thermo Fisher Scientific Company Information
12.5.2 Thermo Fisher Scientific Business Overview
12.5.3 Thermo Fisher Scientific Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.5.4 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.5.5 Thermo Fisher Scientific Recent Developments
12.6 Meridian Bioscience
12.6.1 Meridian Bioscience Company Information
12.6.2 Meridian Bioscience Business Overview
12.6.3 Meridian Bioscience Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.6.4 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.6.5 Meridian Bioscience Recent Developments
12.7 Analytik Jena
12.7.1 Analytik Jena Company Information
12.7.2 Analytik Jena Business Overview
12.7.3 Analytik Jena Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.7.4 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.7.5 Analytik Jena Recent Developments
12.8 Princeton BioMeditech Corporation
12.8.1 Princeton BioMeditech Corporation Company Information
12.8.2 Princeton BioMeditech Corporation Business Overview
12.8.3 Princeton BioMeditech Corporation Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.8.4 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.8.5 Princeton BioMeditech Corporation Recent Developments
12.9 BioMerieux
12.9.1 BioMerieux Company Information
12.9.2 BioMerieux Business Overview
12.9.3 BioMerieux Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.9.4 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.9.5 BioMerieux Recent Developments
12.10 Sekisui Diagnostics
12.10.1 Sekisui Diagnostics Company Information
12.10.2 Sekisui Diagnostics Business Overview
12.10.3 Sekisui Diagnostics Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.10.4 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.10.5 Sekisui Diagnostics Recent Developments
12.11 Response Biomedical
12.11.1 Response Biomedical Company Information
12.11.2 Response Biomedical Business Overview
12.11.3 Response Biomedical Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.11.4 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.11.5 Response Biomedical Recent Developments
12.12 SA Scientific
12.12.1 SA Scientific Company Information
12.12.2 SA Scientific Business Overview
12.12.3 SA Scientific Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.12.4 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.12.5 SA Scientific Recent Developments
12.13 DiaSorin (Focus Diagnostics)
12.13.1 DiaSorin (Focus Diagnostics) Company Information
12.13.2 DiaSorin (Focus Diagnostics) Business Overview
12.13.3 DiaSorin (Focus Diagnostics) Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.13.4 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.13.5 DiaSorin (Focus Diagnostics) Recent Developments
12.14 Wondfo
12.14.1 Wondfo Company Information
12.14.2 Wondfo Business Overview
12.14.3 Wondfo Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.14.4 Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.14.5 Wondfo Recent Developments
12.15 Beijing Wantai Biological Pharmacy
12.15.1 Beijing Wantai Biological Pharmacy Company Information
12.15.2 Beijing Wantai Biological Pharmacy Business Overview
12.15.3 Beijing Wantai Biological Pharmacy Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2020-2025)
12.15.4 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
12.15.5 Beijing Wantai Biological Pharmacy Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings